Results 91 to 100 of about 2,731,118 (178)

Genomic Insights Into Spatiotemporal Dynamics of Acquired Azithromycin Resistance Genes in Salmonella Strains Worldwide

open access: yesFood Safety and Health, Volume 4, Issue 4, Page 939-948, October 2026.
ABSTRACT Azithromycin has been used for clinical invasive infections caused by fluoroquinolone‐ and third‐generation cephalosporin‐resistant Salmonella, and mass drug administration with azithromycin has been used to reduce under‐5 mortality in children in some countries.
Yuhang Pei   +4 more
wiley   +1 more source

The Preparation of Novel Fluorenes Inspired by Hipposudoric Acid

open access: yesHelvetica Chimica Acta, Volume 109, Issue 10, October 2026.
In this research we report on the design and synthesis of a series of fluorene‐based derivatives loosely inspired by the tricyclic framework of hipposudoric acid. Preparation of sixteen novel N‐alkylated derivatives was accomplished via a series of concise one‐step amide N‐alkylation reactions.
Munib Uddin   +3 more
wiley   +1 more source

Emergence of Tigecycline and Carbapenem-Resistant Citrobacter freundii Co-Carrying tmexCD1-toprJ1, blaKPC-2, and blaNDM-1 from a Sepsis Patient

open access: yes, 2023
Jinzhu Huang,* Jinxin Zhao,* Miao Yi, Yaling Yuan, Peiwen Xia, Bingxue Yang, Jiajia Liao, Zijun Dang, Yun Xia* Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ...
Liao J   +8 more
core  

Overexpression of the adeB Efflux Pump Gene in Tigecycline-Resistant Acinetobacter baumannii Clinical Isolates and Its Inhibition by (+)Usnic Acid as an Adjuvant

open access: yes, 2021
Acinetobacter species are among the most life-threatening Gram-negative bacilli, causing hospital-acquired infections, and they are associated with high morbidity and mortality. They show multidrug resistance that acts via various mechanisms.
Sreekanth Reddy Basireddy   +4 more
core   +1 more source

Heteroresistance is associated with mutations during low concentration of tigecycline therapy in multiple-resistant Klebsiella pneumoniae

open access: yesAnnals of Clinical Microbiology and Antimicrobials
Background Heteroresistance can lead to treatment failure and has brought a rigorous challenge to clinical laboratories for detecting them. The aim of this study was to investigate the potential for tigecycline-susceptible Klebsiella pneumoniae (K ...
Qiaoyu Zhang   +5 more
doaj   +1 more source

Mechanisms of tigecycline resistance in the Enterobacteriaceae and Acinetobacter baumannii [PDF]

open access: yes, 2011
Tigecycline is the first glycylcycline to enter clinical use and displays good in vitro activity against a broad range of Gram-positive and Gram-negative pathogens.
Hornsey, Michael Andrew
core   +1 more source

Molecular mechanisms and genomic basis of tigecycline-resistant Enterobacterales from swine slaughterhouses

open access: yes, 2022
The continuous emergence of tigecycline-resistant bacteria is undermining the effectiveness of clinical tigecy-cline. Environmental tigecycline-resistant bacteria have the potential to infect humans through human -environment interactions.
Li, Ruichao   +13 more
core   +1 more source

Developmental dynamics of antibiotic resistome in aerobic biofilm microbiota treating wastewater under stepwise increasing tigecycline concentrations

open access: yesEnvironment International, 2019
This study aimed to investigate the impact of tigecycline, the third generation tetracycline, on the antibiotic resistance development in environmental microbiota.
Zhe Tian   +4 more
doaj   +1 more source

β-lactamase-producing Gram negative isolates and molecular mechanisms involved in the expression of tigecycline resistance [PDF]

open access: yes, 2014
Objectives: The emergence of antibiotic resistant Gram negative bacteria, particularly β-lactamase-producing bacteria, seriously compromises the efficacy of the treatment options available.
Barbosa, Stephanie   +5 more
core  

Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report

open access: yes, 2007
Objectives: Tigecycline has shown in vitro activity against Acinetobacter baumannii. Yet, published clinical experience with tigecycline use outside clinical trials is lacking.
Capitano, B.   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy